Scalpel- (The HIV/AIDS novel)
Scalpel -the hiv/AIDS novel $27
(a fictituous novel that illustrates the global impact of hiv/AIDS)
By N. A. Akamike-crop.jpg)
SCALPEL: [the hiv/aids novel]
IS A FICTITIOUS NOVEL ON THE SCOURGE OF HIV/AIDS.
$27
Suspenseful!! Exciting!! Intriguing!! Compelling!! Don't Miss it.
ISBN: 978-1-4349-6547-9
eISBN: 978-1-4349-4788-8
Jaguda is a maverick scientist who set out to rescue a failing giant pharmaceutical company. He attempts to develop new antiretroviral, ARV, drugs for HIV that will be revolutionary. First, he reviews the existing pipeline of drugs in order to redesign them. Second, he shifts his company's research and development, R & D, from stem cell reserach to conventional medicinal chemistry approaches. The problems become complicated and magnified. The international implication of the pandemic is imminent. The company's board of directors is nervous.
Although he is married yet he falls in love with his secretary who, incidentally, does not love him. He persuades her to go on a secret romantic rendezvous in Paris on corporate account. Following a series of corporate espionage by internal affairs, his illicit affair with his secretary is exposed. His wife later finds out. The turbulence of marital infidelity follows.
His ambitious and desperate attempt to dominate the pharmaceutical industry leads him towards a buy-out plot pf a smaller biotech pharma that has discovered a revolutionary compound for the global eradication of AIDS. The discovery is made after the biotech pharma investigates the HIV epidemic in the Democratic Republic of Congo, DRC, in the Sub-Sahara Africa. The intriguing, undercover involvement of hired detectives, his office romance, compounded by unhappy board members and stakeholders, laced together, culminates in a series of adverse effect. Did he survive?
####################################################
Author Bio:
N. A. Akamike is a research scientist in pharmaceutical sciences, a recipient of the sigma xi award, the inventor on four patents related to cancer and a coauthor of several scientific publications in the area of HIV/AIDS. The author of Soft Tissue, a novel on breast cancer.
email: gsofttissue@gmail.com
Jaguda is a maverick scientist who set out to rescue a failing giant pharmaceutical company. He attempts to develop new antiretroviral, ARV, drugs for HIV that will be revolutionary. First, he reviews the existing pipeline of drugs in order to redesign them. Second, he shifts his company's research and development, R & D, from stem cell reserach to conventional medicinal chemistry approaches. The problems become complicated and magnified. The international implication of the pandemic is imminent. The company's board of directors is nervous.
Although he is married yet he falls in love with his secretary who, incidentally, does not love him. He persuades her to go on a secret romantic rendezvous in Paris on corporate account. Following a series of corporate espionage by internal affairs, his illicit affair with his secretary is exposed. His wife later finds out. The turbulence of marital infidelity follows.
His ambitious and desperate attempt to dominate the pharmaceutical industry leads him towards a buy-out plot pf a smaller biotech pharma that has discovered a revolutionary compound for the global eradication of AIDS. The discovery is made after the biotech pharma investigates the HIV epidemic in the Democratic Republic of Congo, DRC, in the Sub-Sahara Africa. The intriguing, undercover involvement of hired detectives, his office romance, compounded by unhappy board members and stakeholders, laced together, culminates in a series of adverse effect. Did he survive?
####################################################
Author Bio:
N. A. Akamike is a research scientist in pharmaceutical sciences, a recipient of the sigma xi award, the inventor on four patents related to cancer and a coauthor of several scientific publications in the area of HIV/AIDS. The author of Soft Tissue, a novel on breast cancer.
email: gsofttissue@gmail.com